Currently, there is a global environment where the requirements and standards for the provision of quality products to the population grow exponentially. Governments and cross-cutting entities that advocate for Public Health establish these requirements to ensure the commitment of organizations to meet quality standards. Under this scenario, at Q-VANT we seek to comply with the health environment that commits actors from the public, private and academic spheres to contribute positively to society.
The quality of raw materials is essential to ensure that the highest regulatory standards are met in relation to the production of vaccines to take care of the health of the population.
Our mission is to ensure a reliable supply of Quillaja-based saponin precursors and adjuvants, to be used in human and animal vaccines developed to combat diseases and pandemics worldwide.
Therefore, we are committed to achieving high levels of quality in our processes to produce and supply the vaccine adjuvant market by complying with regulatory requirements and those of our customers nationally and internationally.
Consequently, we will maintain objectives that allow us to periodically evaluate the performance of our Quality Management System, and that these help us to promote the continuous improvement of the organization.
